Design
Review
Authors
Loading...
Does not change current practice; leaves open US regulatory pathways for TCI approval.
This article reviews regulatory pathways for the potential clearance or approval of target-controlled infusion of IV anesthetic drugs in the United States.
Paul E. Dryden (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: